Common Sites of Bladder Cancer Metastasis
Bladder cancer most commonly spreads to lymph nodes, bone, lung, liver, and peritoneum, with the specific pattern depending on whether the disease is muscle-invasive at presentation. 1
Metastatic Pattern by Disease Stage
Muscle-Invasive Bladder Cancer (MIBC)
When bladder cancer invades the muscularis propria (detrusor muscle), the risk of distant spread increases substantially. The five most common metastatic sites for MIBC are:
- Lymph nodes (69-90%) - most frequent site 1, 2, 3
- Bone (32-47%) 2, 3
- Lung (37-45%) 2, 3
- Liver (26-47%) 2, 3
- Peritoneum (16-19%) 2, 3
Less common but documented sites include pleura (16%), kidney (14%), adrenal gland (14%), intestine (13%), and brain (rare, <1%) 3.
Lymphatic Drainage Pattern
The lymphatic spread is extensive and complex. Drainage extends beyond the external iliac vessels and obturator fossa to involve:
- Internal iliac vessels
- Common iliac vessels up to the uretero-iliac crossing
- Occasionally extending to the inferior mesenteric artery 1
Important caveat: Traditional size criteria for suspicious lymph nodes (>8mm pelvic, >10mm abdominal) are unreliable, as CT cannot detect microscopic metastases in normal-sized nodes 1, 4.
Prognostic Implications by Metastatic Site
Single-Site Metastases
Among patients with isolated metastases, liver metastasis carries the worst prognosis with a median survival of only 3.7 months, while lung metastasis has the best survival at 8.48 months 5, 6.
Multiple-Site Metastases
Patients with metastases to multiple sites have significantly worse outcomes (median OS: 3.55 months) compared to single-site disease 6.
Molecular Subtype Associations
Recent evidence demonstrates that molecular subtypes show distinct metastatic tropism 7:
- Basal/squamous subtype: Depleted of bone metastases
- Urothelial-like subtype: Enriched for bone metastases
- Genomically unstable subtype: Depleted of lung metastases but enriched for atypical sites, including brain (6 of 7 brain metastases occurred in this subtype)
- Stroma-rich tumors: Associated with local recurrence rather than distant sites
Histologic Variant Considerations
Atypical histologic features (squamous cell, adenocarcinoma, small cell, undifferentiated) are associated with:
- Shorter metastasis-free interval (3 months vs 12 months for transitional cell) 2
- Significantly higher incidence of peritoneal metastasis 1, 2
Temporal Pattern
Most recurrences occur within the first 2 years following cystectomy, with 61.7% being single-site recurrences 8. The high frequency of metastases even in patients undergoing cystectomy indicates that metastasis often occurs before diagnosis, emphasizing the aggressive nature of muscle-invasive disease 3.
Clinical Implications for Staging
Given these patterns, comprehensive staging for MIBC should include:
- CT chest, abdomen, and pelvis to evaluate the most common sites
- Bone imaging when clinically indicated (particularly for Urothelial-like subtype)
- Brain imaging reserved for symptomatic patients or Genomically unstable subtype
- Recognition that 6% of patients have distant metastases at diagnosis, most commonly retroperitoneal lymph nodes 1, 9
Critical pitfall: Non-muscle invasive bladder cancer (NMIBC) rarely metastasizes at presentation (0.74% incidence), so extensive metastatic workup is not routinely indicated for Ta-T1 disease 6.